ticlopidine has been researched along with DDD MPGNII in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Splendiani, G | 1 |
| Costanzi, S | 1 |
| Sturniolo, A | 1 |
| Passalacqua, S | 1 |
| Fulignati, P | 1 |
| Piccinni, G | 1 |
| Federico, F | 1 |
| Chiarelli, C | 1 |
1 trial available for ticlopidine and DDD MPGNII
| Article | Year |
|---|---|
Treatment of idiopathic glomerulonephritis in the elderly. Personal data.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Glomerulonephritis; Glomerulonephri | 1993 |